Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03561220 · ClinicalTrials.gov registry record · NA

A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer

A NA study of Prostate Cancer, sponsored by University of Florida.

Active
Registry status
NA
Development phase
3,000
Enrollment target
20
Study locations

NCT03561220 is a NA study of Prostate Cancer that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 3,000 participants, above the 604-participant average among 735 other Prostate Cancer trials with a reported enrollment target (397% higher). The trial reports 20 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03561220, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by University of Florida.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
3,000 participants
Enrollment target
20
Study locations

Study Summary

This study is a large, prospective, pragmatic, controlled comparison of patient-centric outcomes \[quality of life (QOL), toxicity, and disease control\] between parallel cohorts of men with prostate cancer treated simultaneously at proton therapy facilities and at geographically similar conventional (photon-based) radiation facilities using intensity-modulated radiation therapy (IMRT) techniques.

Conditions Studied

Prostate Cancer

Interventions

  • RADIATION Standard of Care IMRT (Photon)
  • RADIATION Standard of Care Proton Therapy
  • RADIATION Proton Arm 1: Standard Proton Therapy
  • RADIATION Proton Arm 2: Hypofractionated Proton Therapy

Study Locations (20)

Florida

  • Department of Radiation Oncology Davis Cancer Pavilion - Gainesville
  • University of Florida Proton Therapy Institute - Jacksonville
  • Ackerman Cancer Center - Jacksonville
  • Mayo Clinic - Jacksonville
  • University of Miami School of Medicine - Miami
  • Miami Cancer Institute - Miami
  • Orlando Health UF Health Center - Orlando

California

  • University of California San Diego - La Jolla
  • Proton Therapy Treatment Center - Loma Linda University - Loma Linda
  • Sutter Health - Roseville
  • California Protons Cancer Therapy Center - San Diego

Illinois

  • University of Chicago - Chicago
  • Northwestern Medicine Proton Center - Warrenville

Maryland

  • Johns Hopkins University - Baltimore
  • University of Maryland - College Park

Alabama

  • University of Alabama at Birmingham (UAB) - Birmingham

Georgia

  • Winship Cancer Institute - Emory University - Atlanta

Kansas

  • University of Kansas Medical Center - Lawrence

Kentucky

  • University of Louisville - Louisville

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2018-07-05
Est. Completion 2027-07-01
Phase NA

Sponsor

University of Florida

1,106 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03561220

The ClinicalTrials.gov registry entry for NCT03561220 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 604-participant average among 735 other Prostate Cancer trials with a reported enrollment target (397% higher). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 4 interventions - of which Standard of Care IMRT (Photon) is the first listed.

NCT03561220 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Florida, California, Illinois.

Frequently Asked Questions

What is clinical trial NCT03561220 about?

NCT03561220 is a clinical study titled "A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer". This study is a large, prospective, pragmatic, controlled comparison of patient-centric outcomes \[quality of life (QOL), toxicity, and disease control\] between parallel cohorts of men with prostate cancer treated simultaneously at proton therapy facilities and at geographically similar conventiona...

What is the current status of trial NCT03561220?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2018-07-05. Estimated completion is 2027-07-01.

What conditions does trial NCT03561220 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT03561220?

The interventions under investigation include: Standard of Care IMRT (Photon) (RADIATION), Standard of Care Proton Therapy (RADIATION), Proton Arm 1: Standard Proton Therapy (RADIATION), Proton Arm 2: Hypofractionated Proton Therapy (RADIATION).

Who is sponsoring clinical trial NCT03561220?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03561220 being conducted?

This trial has 20 study locations across Alabama, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.